Sort   by:  
 Page size 
UnknownClinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights.
Not available
S-EPMC10547146 | biostudies-literature
UnknownThe complete genomic sequence of 424,015 bp at the centromeric end of the HLA class I region: gene content and polymorphism.
Not available
S-EPMC21366 | biostudies-literature
UnknownA highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors.
Not available
S-EPMC10751915 | biostudies-literature
UnknownING3 is required for ATM signaling and DNA repair in response to DNA double strand breaks.
Not available
S-EPMC6889383 | biostudies-literature
UnknownThe Identification of New c-FLIP Inhibitors for Restoring Apoptosis in TRAIL-Resistant Cancer Cells.
Not available
S-EPMC10814526 | biostudies-literature
UnknownPatient-centric synthetic data generation, no reason to risk re-identification in biomedical data analysis
Not available
S-EPMC10006164 | biostudies-literature
UnknownOrthotopic model of lung cancer: isolation of bone micro-metastases after tumor escape from Osimertinib treatment.
Not available
S-EPMC8111918 | biostudies-literature
UnknownGenomic characteristics and clinical significance of CD56+ circulating tumor cells in small cell lung cancer.
Not available
S-EPMC9984363 | biostudies-literature
UnknownAfatinib or Bevacizumab in combination with Osimertinib efficiently control tumor development in orthotopic murine models of non-small lung cancer.
Not available
S-EPMC11210880 | biostudies-literature
UnknownLectin-like transcript 1 is a marker of germinal center-derived B-cell non-Hodgkin's lymphomas dampening natural killer cell functions.
Not available
S-EPMC4570132 | biostudies-literature
Sort   by:  
 Page size